BACKGROUND: Severe or extreme obesity in children and adolescents is a progressive damaging disease, increasingly requiring surgical treatment. Timing and choice of operation are controversial. METHOD: In the last 16 years, we performed open biliopancreatic diversion with duodenal switch (DS) in 13 adolescents aged 15-17 years, who have been followed up for 2-16 years (mean, 10.6 years); three with Prader-Willi syndrome (PWS) are presented separately. RESULTS: Among the ten non-PWS children (7 girls), no deaths or perioperative complications were reported, mean body mass index (BMI) decreased from 55.9 ± 14.0 to 28.8 ± 3.7 kg/m(2) (% excess weight loss (EWL) = 82.1 ± 10.5%), and none have regained weight. All comorbidities were cured except asthma, which improved in one patient. There were two reoperations: one for intestinal obstruction and one for post-anastomotic ulcer. Glucose and lipid metabolism improved, while vitamin and mineral deficiencies were mild and rare. Five of the seven girls gave birth to 11 children, aged 2-12 years, two of whom are overweight but not severely obese. Neurodevelopment is age-appropriate in all 11 individuals. PWS children, aged 15-16 years, had postoperative respiratory and infectious complications necessitating hospitalizations of 13-22 days (versus 5.1 ± 1.2 days in non-PWS). Weight loss and comorbidity improvement lasted approximately 5 years, providing improved quality of life for patient and family. One PWS patient died from complications after reoperation for weight regain after 4 years. One was reoperated after 6 years and the third is considering reoperation 14 years after primary DS. CONCLUSION: The beneficial effects of DS in adolescents exceed the risks, even in the presence of PWS.
BACKGROUND: Severe or extreme obesity in children and adolescents is a progressive damaging disease, increasingly requiring surgical treatment. Timing and choice of operation are controversial. METHOD: In the last 16 years, we performed open biliopancreatic diversion with duodenal switch (DS) in 13 adolescents aged 15-17 years, who have been followed up for 2-16 years (mean, 10.6 years); three with Prader-Willi syndrome (PWS) are presented separately. RESULTS: Among the ten non-PWSchildren (7 girls), no deaths or perioperative complications were reported, mean body mass index (BMI) decreased from 55.9 ± 14.0 to 28.8 ± 3.7 kg/m(2) (% excess weight loss (EWL) = 82.1 ± 10.5%), and none have regained weight. All comorbidities were cured except asthma, which improved in one patient. There were two reoperations: one for intestinal obstruction and one for post-anastomotic ulcer. Glucose and lipid metabolism improved, while vitamin and mineral deficiencies were mild and rare. Five of the seven girls gave birth to 11 children, aged 2-12 years, two of whom are overweight but not severely obese. Neurodevelopment is age-appropriate in all 11 individuals. PWSchildren, aged 15-16 years, had postoperative respiratory and infectious complications necessitating hospitalizations of 13-22 days (versus 5.1 ± 1.2 days in non-PWS). Weight loss and comorbidity improvement lasted approximately 5 years, providing improved quality of life for patient and family. One PWSpatient died from complications after reoperation for weight regain after 4 years. One was reoperated after 6 years and the third is considering reoperation 14 years after primary DS. CONCLUSION: The beneficial effects of DS in adolescents exceed the risks, even in the presence of PWS.
Authors: Paul W Franks; Robert L Hanson; William C Knowler; Maurice L Sievers; Peter H Bennett; Helen C Looker Journal: N Engl J Med Date: 2010-02-11 Impact factor: 91.245
Authors: Francesco S Papadia; Gian Franco Adami; Giuseppe M Marinari; Giovanni Camerini; Nicola Scopinaro Journal: Surg Obes Relat Dis Date: 2007-04-02 Impact factor: 4.734
Authors: Gerd R Silberhumer; Karl Miller; Stefan Kriwanek; Kurt Widhalm; Antonia Pump; Gerhard Prager Journal: Obes Surg Date: 2006-08 Impact factor: 4.129
Authors: Melissa A Kalarchian; Michele D Levine; Silva A Arslanian; Linda J Ewing; Patricia R Houck; Yu Cheng; Rebecca M Ringham; Carrie A Sheets; Marsha D Marcus Journal: Pediatrics Date: 2009-09-28 Impact factor: 7.124
Authors: V A Holm; S B Cassidy; M G Butler; J M Hanchett; L R Greenswag; B Y Whitman; F Greenberg Journal: Pediatrics Date: 1993-02 Impact factor: 7.124
Authors: Wiebke V Petersen; Tobias Meile; Markus A Küper; Marty Zdichavsky; Alfred Königsrainer; Joachim H Schneider Journal: Obes Surg Date: 2012-03 Impact factor: 4.129
Authors: Ann O Scheimann; Merlin G Butler; Jennifer L Miller; Phillip D K Lee; David A Stevenson; Janalee Heinemann; Daniel J Driscoll Journal: Obes Surg Date: 2012-03 Impact factor: 4.129
Authors: Miguel A Carbajo; Gilberto Gonzalez-Ramirez; Jose Maria Jimenez; Enrique Luque-de-Leon; Javier Ortiz-de-Solorzano; Maria Jose Castro; Jaime Ruiz-Tovar Journal: Obes Surg Date: 2019-09 Impact factor: 4.129
Authors: B S Lennerz; M Wabitsch; H Lippert; S Wolff; C Knoll; R Weiner; T Manger; W Kiess; C Stroh Journal: Int J Obes (Lond) Date: 2013-09-19 Impact factor: 5.095